Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.89B | 9.70B | 10.08B | 10.40B | 9.84B | 10.01B |
Gross Profit | 3.10B | 3.09B | 3.17B | 3.50B | 3.25B | 2.91B |
EBITDA | 1.03B | 1.12B | 1.23B | 1.62B | 1.24B | 1.14B |
Net Income | 438.05M | 429.90M | 487.51M | 750.10M | 499.19M | 329.71M |
Balance Sheet | ||||||
Total Assets | 25.01B | 25.26B | 25.07B | 23.59B | 22.79B | 22.65B |
Cash, Cash Equivalents and Short-Term Investments | 3.05B | 3.70B | 3.96B | 5.76B | 5.54B | 4.96B |
Total Debt | 800.00M | 800.00M | 801.46M | 1.61B | 1.62B | 1.66B |
Total Liabilities | 4.62B | 4.55B | 4.70B | 5.38B | 5.39B | 5.36B |
Stockholders Equity | 19.95B | 20.24B | 19.93B | 17.81B | 17.02B | 16.96B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 198.34M | 109.10M | 498.98M | 1.01B | 630.77M |
Operating Cash Flow | 0.00 | 1.06B | 611.39M | 1.06B | 1.28B | 1.05B |
Investing Cash Flow | 0.00 | -753.61M | -934.50M | -562.01M | -251.25M | -690.90M |
Financing Cash Flow | 0.00 | -623.28M | -1.33B | -262.46M | -431.97M | 411.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥234.14B | 8.52 | 3.75% | 6.59% | 18.36% | ||
80 Outperform | ¥100.53B | 8.64 | 3.96% | 1.25% | 21.02% | ||
76 Outperform | ¥47.29B | 10.91 | 3.20% | -21.30% | -13.68% | ||
72 Outperform | €143.95B | 8.36 | 6.67% | 3.93% | -2.43% | ― | |
71 Outperform | ¥8.04B | 19.34 | 4.34% | -3.80% | -9.74% | ||
71 Outperform | ¥123.97B | 14.10 | 2.47% | -0.43% | 42.04% | ||
71 Outperform | ¥254.47B | 13.17 | 8.49% | 3.06% | 6.31% | 13.07% |